![In the last few years, the miR-34a family has emerged as a pleiotropic... | Download Scientific Diagram In the last few years, the miR-34a family has emerged as a pleiotropic... | Download Scientific Diagram](https://www.researchgate.net/profile/Massimiliano-Agostini/publication/261033718/figure/fig1/AS:202888652562456@1425383832296/In-the-last-few-years-the-miR-34a-family-has-emerged-as-a-pleiotropic-microRNA-It-was.png)
In the last few years, the miR-34a family has emerged as a pleiotropic... | Download Scientific Diagram
![MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing](https://www.spandidos-publications.com/article_images/or/45/3/OR-45-03-0911-g02.jpg)
MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing
![microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/edf7c252-3a6c-4250-8feb-067fe8a574b1/wrna1662-toc-0001-m.jpg)
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
![Delivery of biologically active miR-34a in normal and cancer mammary epithelial cells by synthetic nanoparticles - ScienceDirect Delivery of biologically active miR-34a in normal and cancer mammary epithelial cells by synthetic nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1549963419300759-ga1.jpg)
Delivery of biologically active miR-34a in normal and cancer mammary epithelial cells by synthetic nanoparticles - ScienceDirect
![Frontiers | MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic | Cell and Developmental Biology Frontiers | MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/640587/fcell-09-640587-HTML/image_m/fcell-09-640587-g001.jpg)
Frontiers | MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic | Cell and Developmental Biology
![MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction | Circulation Research MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction | Circulation Research](https://www.ahajournals.org/cms/asset/35ba053d-a301-4755-8428-99d337759e59/450fig03.jpeg)
MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction | Circulation Research
![Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment | Scientific Reports Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-18186-0/MediaObjects/41598_2017_18186_Fig1_HTML.jpg)
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment | Scientific Reports
![miRNA Therapeutics Heading to the Clinic: Despite Great Challenges, a Number of Companies Are Committed to Development Programs: Genetic Engineering & Biotechnology News: Vol 34, No 3 miRNA Therapeutics Heading to the Clinic: Despite Great Challenges, a Number of Companies Are Committed to Development Programs: Genetic Engineering & Biotechnology News: Vol 34, No 3](https://www.liebertpub.com/cms/10.1089/gen.34.03.06/asset/images/medium/gen.34.03.06.t001.png)
miRNA Therapeutics Heading to the Clinic: Despite Great Challenges, a Number of Companies Are Committed to Development Programs: Genetic Engineering & Biotechnology News: Vol 34, No 3
![Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours | British Journal of Cancer Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-0802-1/MediaObjects/41416_2020_802_Fig1_HTML.png)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours | British Journal of Cancer
![MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer | Journal of Experimental & Clinical Cancer Research | Full Text MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-019-1059-5/MediaObjects/13046_2019_1059_Fig3_HTML.png)